| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.1 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.1 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.24 | 0.1 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.074 | 0.1 |